All Nippon Airways (ANA) has tweaked its Boeing 787 orders, converting some from the -10 variant to -9s. The carrier informed the stock exchange on March 25 that its board had approved an amendment to ...

Middle Eastern operator Flydubai will start increasing its complement of Boeing 737 Max 9s this year, the larger variant accounting for more than half of the 12 Max jets it expects to receive in 2026.

Don’t think twice, it’s all right. Bob Dylan’s earliest New York recordings are finally getting their due. “The Bootleg Series Vol. 18: Through the Open Window, 1956‑1963,” a massive collection of ...

In the last week, two former Tesla self-driving/Autopilot program leaders have commented on the state of autonomous driving, telling a very different story than their former boss, Elon Musk. Elon Musk ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

PARIS, Oct 9 (Reuters) - French President Emmanuel Macron said on Thursday that the coming hours will be decisive for cementing peace in Gaza and that the current conference on the matter held in ...

SPUS is a leading Shariah-compliant U.S. equity comprised of roughly 200 S&P 500 Index stocks. Its expense ratio is 0.45%, and the ETF has $1.64B in assets under management. Despite the suggestion, ...

A research team at the Medical University of South Carolina reports in Cells that the complement system, part of the body's natural immune defenses, is a key driver of inflammatory responses that ...

Panama’s Copa Airlines may not convert options it holds for more than a dozen Boeing 737 Max 10s into orders, as chief executive Pedro Heilbron expresses satisfaction with the carrier’s current mix of ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how an anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA ...